Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.
Clin Cancer Res. 2023 Jan 17;29(2):502. doi: 10.1158/1078-0432.CCR-22-3712.
Clin Cancer Res. 2023.
PMID: 36647675
No abstract available.
Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.
Thomas RP, Nagpal S, Iv M, Soltys SG, Bertrand S, Pelpola JS, Ball R, Yang J, Sundaram V, Lavezo J, Born D, Vogel H, Brown JM, Recht LD.
Thomas RP, et al. Among authors: pelpola js.
Clin Cancer Res. 2019 Dec 1;25(23):6948-6957. doi: 10.1158/1078-0432.CCR-19-1421. Epub 2019 Sep 19.
Clin Cancer Res. 2019.
PMID: 31537527
Free PMC article.
Clinical Trial.
Item in Clipboard
NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.
Hatton O, Strauss-Albee DM, Zhao NQ, Haggadone MD, Pelpola JS, Krams SM, Martinez OM, Blish CA.
Hatton O, et al. Among authors: pelpola js.
Front Immunol. 2016 Dec 15;7:607. doi: 10.3389/fimmu.2016.00607. eCollection 2016.
Front Immunol. 2016.
PMID: 28018364
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.